J&J COVID-19 Vaccine – ACIP Recommends Continued Use
On April 23, 2021 - The CDC’s Advisory Committee on Immunization Practices (ACIP) convened an emergency meeting to reassess the risk benefit profile of the Johnson & Johnson (J&J) coronavirus vaccine.
Download PDF
